About Quanta Dialysis Technologies
Quanta Dialysis Technologies is a Healthcare company based in Alcester (United Kingdom) founded in 2008 by Clive Henry Buckberry. Haemodialysis systems are developed for home and clinic applications. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Quanta Dialysis Technologies has raised $432.84 million across 9 funding rounds from investors including Air Liquide, BlackRock and IMI. The company has 100 employees. Quanta Dialysis Technologies was last valued at $103.2 million in June 2017. Quanta Dialysis Technologies offers products and services including Quanta Dialysis System and Trinal Kidney Therapy (TKT). Its focus areas include Medical Devices and Dialysis Equipment. Its legal entity is Quanta Dialysis Technologies Inc.
Company details
Quanta Dialysis Technologies is engaged in developing advanced dialysis systems for kidney care. The company operates in the healthcare sector, specializing in medical devices. Its flagship product, the Quanta Dialysis System, offers versatile treatment options across various care settings. Solutions are designed to enhance efficiency and flexibility for healthcare providers and patients. The focus is on delivering innovative care through compact, user-friendly technology.
- Headquarters Alcester, United Kingdom
- Employees 100
- Founders Clive Henry Buckberry
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website quantadt.com
- Social LinkedIn X Facebook
- Legal Name Quanta Dialysis Technologies Inc.
- Annual Revenue$1.4 M (USD)39as on Dec 31, 2022
- Net Profit-$54.63 M (USD)-82as on Dec 31, 2022
- EBITDA-$60.51 M (USD)-75as on Dec 31, 2022
- Total Equity Funding$432.84M (USD)
in 9 rounds
- Latest Funding Round$60M (USD), Series E
Nov 2024
- InvestorsAir Liquide
& 27 more
- Employee Count100
Products & Services of Quanta Dialysis Technologies
Quanta Dialysis Technologies offers a comprehensive portfolio of products and services, including Quanta Dialysis System and Trinal Kidney Therapy (TKT).
A compact system for advanced kidney dialysis therapies.
Innovative therapy combining multiple dialysis treatment modalities.
Funding Insights of Quanta Dialysis Technologies
Quanta Dialysis Technologies has successfully raised a total of $432.84M across 9 strategic funding rounds. The most recent funding activity was a Series E round of $60 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $432.84M
- Total Rounds 9
- Last Round Series E — $60M
- First Round $14.33M
(Sep 2009)
- Investors Count 28
All 9 funding rounds of Quanta Dialysis Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $60M | Series E | – | Novo Holdings | |
| Jun 2021 | $245M | Series D | – | Novo Holdings | |
| Jul 2019 | $47.03M | Series C | – | b2venture, Wellington Partners Venture Capital | |
| Jun 2017 | $5.9M | Series B | $103.2M | Air Liquide, Aliada | |
| Aug 2015 | $2.89M | Grant | – | – | |
| Oct 2014 | $50.4M | Series B | $107.44M | Air Liquide | |
| Mar 2012 | $10.17M | Series A | – | – | |
| Aug 2010 | $1.71M | Grant | – | – | |
| Sep 2009 | $14.33M | Series A | – | Stage Capital, Seroba Life Sciences |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2017 | $103.2M | •••••••• |
| Oct 2014 | $107.44M | •••••••• |
Last known valuation $103.2M (Jun 2017). 28 investors in total: 26 institutional and 2 angel.
Investors in Quanta Dialysis Technologies
Quanta Dialysis Technologies has secured backing from 28 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Air Liquide, BlackRock and IMI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
Venture capital is provided to innovative startups by b2venture. | b2venture.vc | St. Gallen, Switzerland | ||
Holding company investing in insurance, asset management, technology, mobility, sports, music, real estate, and consumer sectors | eldridge.com | Miami, United States | ||
Health and technology startups are invested in by Puhua Capital. | puhuacapital.com | Hangzhou, China | ||
Investments are made in early-stage healthcare startups. | wellington-partners.com | Munich, Germany | ||
Venture capital fund focused on digital health and digital medical device companies | mtip.ch | Basel, Switzerland | ||
Kuwait Life Sciences Company is engaged in healthcare investments and technology transfer in the MENA region. | 2010 | klsc.com.kw | Sharq, Kuwait | |
Merifin Capital is recognized as a European private investment group. | merifin.com | Brussels, Belgium | ||
Stage Capital is focused on private equity investments. | stagecap.com | London, United Kingdom | ||
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US | seventure.fr | Paris, France |
Investor details for Quanta Dialysis Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Quanta Dialysis Technologies
21 people are tracked at Quanta Dialysis Technologies (8 in leadership, 11 in board & advisors, 2 in team); the tracked headcount is 100.
| Name | Role | Group |
|---|---|---|
Clive Henry Buckberry | Co-Founder | Leadership |
Alejandro Galindo | CEO | Leadership |
Jonathan Isenburg | Chief Financial Officer | Leadership |
Paul Komenda | Chief Medical Officer | Leadership |
John Lipman | President, North America | Leadership |
Clive Buckberry | Chief of Technology and Engineering | Leadership |
Suzanne Sickler | Director Of Finance - US | Leadership |
George Maynard | General Counsel, Company Secretary & Head Of People & Performance | Leadership |
Johan De Ruiter | Board Member, Chair Remcom | Board & advisors |
Rainer Strohmenger | Non-Executive Director | Board & advisors |
Christian Schuetz | Non-Executive Director | Board & advisors |
John Agar | Medical Advisory Board Member | Board & advisors |
Nicholas Hoenich | Medical Advisory Board Member | Board & advisors |
Tony Goovaerts | Medical Advisory Board Member | Board & advisors |
Elizabeth Lindley | Medical Advisory Board Member | Board & advisors |
Roger Greenwood | Medical Advisory Board Member | Board & advisors |
Peter Kerr | Medical Advisory Board Member | Board & advisors |
Sandip Mitra | Medical Advisory Board Member | Board & advisors |
Peter Sandys | Non-Executive Director | Board & advisors |
Bradley Thomas | Financial Systems Manager | Team |
1 more people are available in the full profile.
Complete people profiles for Quanta Dialysis Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Quanta Dialysis Technologies
4 dated milestones of Quanta Dialysis Technologies across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Quanta Dialysis Technologies is founded.
- Funding First funding round of $14.3M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series E, of $60.0M.
Web traffic of Quanta Dialysis Technologies
The website of Quanta Dialysis Technologies (quantadt.com) receives about 10K visits a month.
- Monthly visits10K
▲ 1.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Quanta Dialysis Technologies
Complete news archive for Quanta Dialysis Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quanta Dialysis Technologies
Quanta Dialysis Technologies was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Quanta Dialysis Technologies is headquartered in Alcester, United Kingdom. It is registered at Alcester, Warwickshire, United Kingdom.
Quanta Dialysis Technologies is a funded company, having raised a total of $432.84M across 9 funding rounds to date. The company's 1st funding round was a Series A of $14.33M, raised on Sep 2009.
Quanta Dialysis Technologies has 100 employees.
Annual revenue of Quanta Dialysis Technologies is $1.4M as on Dec 31, 2022.
Quanta Dialysis Technologies is engaged in developing advanced dialysis systems for kidney care. The company operates in the healthcare sector, specializing in medical devices. Its flagship product, the Quanta Dialysis System, offers versatile treatment options across various care settings. Solutions are designed to enhance efficiency and flexibility for healthcare providers and patients. The focus is on delivering innovative care through compact, user-friendly technology.
Quanta Dialysis Technologies offers Quanta Dialysis System and Trinal Kidney Therapy (TKT).
Quanta Dialysis Technologies has 28 investors. Key investors include Air Liquide, BlackRock, IMI, Orlando Health, and Aliada.
The valuation of Quanta Dialysis Technologies is $103.2M as of Jun 2017.
Quanta Dialysis Technologies operates through Quanta Dialysis Technologies Inc..